PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsOctinoxate
Octinoxate
Shade Uvaguard (octinoxate) is a small molecule pharmaceutical. Octinoxate was first approved as Shade uvaguard on 1992-12-07.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Avobenzone
+
Octinoxate
+
Oxybenzone
Tradename
Company
Number
Date
Products
SHADE UVAGUARDBayerN-020045 DISCN1992-12-07
1 products, RLD
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
abalone crystaldouble ex bbunapproved drug other2017-03-10
abalone crystaldouble ex ccunapproved drug other2017-03-10
absolut skin spf 50 moisturizing sunscreenC2002632025-06-19
alba botanica natural very emollient sunscreen kids spf40OTC monograph final2012-05-03
alba botanica natural very emollient sunscreen spf40OTC monograph final2012-04-30
alba botanica natural very emollient sunscreen sport spray spf40OTC monograph final2012-05-08
alba hawaiian green tea sunblock spf 45OTC monograph not final2010-07-13
alba lip care sunblock spf 25OTC monograph not final2010-07-26
alba sunblock natural kids spf 45OTC monograph not final2010-07-09
alba sunblock natural lavender spf 45OTC monograph not final2010-07-06
Show 169 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
photosensitivity disorders—D010787L57.1
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
D: Dermatologicals
— D02: Emollients and protectives
— D02B: Protectives against uv-radiation
— D02BA: Protectives against uv-radiation for topical use
— D02BA02: Octinoxate
HCPCS
No data
Clinical
Clinical Trials
10 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sun protection factorD059405————1——1
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameOctinoxate
INNoctinoxate
Description
Octyl 4-methoxycinnamic acid is a cinnamate ester.
Classification
Small molecule
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1
Identifiers
PDB—
CAS-ID5466-77-3
RxCUI—
ChEMBL IDCHEMBL3183184
ChEBI ID—
PubChem CID5355130
DrugBankDB09496
UNII ID4Y5P7MUD51 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 607 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
11,993 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use